Do you know the adverse side reactions of 4 new FDA-approved drugs?
New drugs, namely, Vyvgart, Cytalux, Livtencity, and Besremi approved in 2021 by FDA showed adverse effects in clinical trials....
FDA
FDA approves first treatment for congenital athymia
Congenital athymia is a rare condition in which babies are born without a thymus. As a result, the immune...
FDA Approves Pradaxa (Dabigatran Etexilate), the First Oral Anticoagulant for Children
The Food and Drug Administration approves Boehringer Ingelheim’s Pradaxa (dabigatran etexilate) oral pellets to treat venous thromboembolism (VTE) in children aged 3...
Avapritinib approved by FDA for use in systemic mastocytosis
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...
Dapagliflozin approved for use in chronic kidney disease
The SGLT2 inhibitors, or gliflozins, have been rising stars in the fields of endocrinology and cardiology for their ability...
FDA Approves Pembrolizumab, the First Anti-PD1 Therapy for HER2 Positive Gastric Cancer
The Food and Drug Administration grants accelerated approval to Merck’s Keytruda (pembrolizumab), the checkpoint inhibitor drug for HER2-positive gastric...
IpsiHand Stroke Rehab System Receives FDA Market Authorization
FDA has authorized marketing for the first-of-its-kind device to assist upper limb rehabilitation of stroke patients.1 In 2017, a...
FDA Approves First Trial of CRISPR for Sickle Cell Disease
The U.S Food and Drug Administration (FDA) has approved the first clinical trial of CRISPR to correct sickle cell...
First-in-class drug approved for bone marrow protection during chemotherapy
Chemotherapy can be lifesaving, but it can also damage bone marrow and cause blood cell counts to drop, sometimes...
FDA approves Qelbree, a Non-stimulant Treatment for ADHD
The FDA has approved Qelbree (SPN-812), for children aged 6 to 17 years with attention deficit hyperactivity disorder (ADHD)....